Vir

Chimerix

This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.

VIRX

Viracta Therapeutics develops precision oncology medicines targeting virus-associated cancers for patients with Epstein-Barr virus-positive lymphomas and solid tumours.

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.

Corus Pharmaceuticals

This company develops biopharmaceutical medicines to treat patients with HIV, viral hepatitis, cancer and inflammatory diseases.

Enanta

This biotechnology company develops small molecule medicines to treat viral infections and immunological diseases for patients with serious medical conditions.

Atea

This biopharmaceutical company develops oral antiviral therapies for patients with serious viral infections, including hepatitis C and other ribonucleic acid virus diseases.

Arsanis

This biotechnology company develops monoclonal antibodies to treat and prevent serious infectious diseases for patients with life-threatening bacterial and viral infections.

Invivyd

Invivyd develops monoclonal antibody therapies to protect immunocompromised patients from serious viral infectious diseases, including COVID-19 and measles.